Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP12A | P54707 | 5/20 | 0.69 |
| ▸ | ATP1A1 | P05023 | 4/20 | 0.69 |
| ▸ | ATP1B1 | P05026 | 4/20 | 0.69 |
| ▸ | ATP1A3 | P13637 | 4/20 | 0.69 |
| ▸ | ATP1B2 | P14415 | 4/20 | 0.69 |
| ▸ | ATP1A2 | P50993 | 4/20 | 0.69 |
| ▸ | ATP1B3 | P54709 | 4/20 | 0.69 |
| ▸ | FXYD2 | P54710 | 4/20 | 0.69 |
| ▸ | ATP1A4 | Q13733 | 4/20 | 0.69 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 4/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.31 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cassaine SCHEMBL4167835 | 0.82 | ATP12A (1.00) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| Cassaine SCHEMBL4167834 | 0.82 | ATP12A (1.00) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL31237867 | 0.79 | ATP1A1 (0.47) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| Cassaine SCHEMBL7805406 | 0.79 | ATP12A (0.93) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL11892867 | 0.77 | ATP12A (0.84) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL677461 | 0.77 | ATP12A (0.84) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL5087938 | 0.74 | ATP12A (0.81) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL30714764 | 0.73 | ATP1A1 (0.41) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL309088 | 0.73 | ATP1A1 (0.41) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 | |
| SCHEMBL309087 | 0.73 | ATP1A1 (0.41) | ATP12AATP1A1ATP1B1ATP1A3ATP1B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104150808-B | For improving the method and additive of construction composition and substrate adherence | 阿克佐诺贝尔化学国际公司 | 2017-11-17 | — | — | CN | disclosed |
| US-9353005-B2 | Process for production of powder redispersible in water and use thereof | AKZO NOBEL N.V. (NL) | 2016-05-31 | — | — | US | disclosed |
| CN-102781869-B | Method and additive for improving adhesion of building compositions to substrates | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2015-08-05 | — | — | CN | disclosed |
| CN-104150808-A | Process and additive to improve adhesion of building compositions to substrates | AKZO NOBEL CHEMICALS INT BV | 2014-11-19 | — | — | CN | disclosed |
| US-20140316029-A1 | PROCESS FOR PRODUCTION OF POWDER REDISPERSIBLE IN WATER AND USE THEREOF | AKZO NOBEL N.V. (NL) | 2014-10-23 | — | — | US | disclosed |
| CN-101272994-B | Powder redispersible in water, process for production thereof and use thereof | ELOTEX AG | 2013-04-03 | — | — | CN | disclosed |
| CN-102781869-A | Method and additive for improving adhesion of building compositions to substrates | AKZO NOBEL CHEMICALS INT BV | 2012-11-14 | — | — | CN | disclosed |
| US-20120264861-A1 | POWDER REDISPERSIBLE IN WATER, PROCESS FOR PRODUCTION THEREOF AND USE THEREOF | AKZO NOBEL N.V. (NL) | 2012-10-18 | — | — | US | disclosed |
| WO-2010009091-A2 | ANTI-INFLAMMATORY AND ANTI-ALLERGY EXTRACTS FROM NETTLE | HERBALSCIENCE GROUP, LLC (US) | 2010-01-21 | — | — | WO | disclosed |
| US-20100009927-A1 | Anti-Inflammatory and Anti-Allergy Extracts from Nettle | HERBALSCIENCE GROUP LLC (US) | 2010-01-14 | — | — | US | disclosed |
| EP-1005324-B1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIV NEBRASKA (US) | 2005-03-30 | — | — | EP | disclosed |
| US-6831101-B2 | Compounds that bind to one or more RANTES receptors for treatment of chemokine mediated disease states | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2004-12-14 | — | — | US | disclosed |
| US-20030229029-A1 | Cardiac glycosides for treating muscle pain and spasm | LAUDADIO CHARLES (US) | 2003-12-11 | — | — | US | disclosed |
| US-20030125380-A1 | Tricyclic rantes receptor ligands | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2003-07-03 | — | — | US | disclosed |
| US-20030092674-A1 | Tricyclic rantes receptor ligands | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2003-05-15 | — | — | US | disclosed |
| WO-2002102365-A1 | TRICYCLIC TERPENES OF THE FAMILY OF ABIETIC ACID AS RANTES RECEPTOR LIGANDS | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2002-12-27 | — | — | WO | disclosed |
| EP-1005324-A4 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIV NEBRASKA (US) | 2001-06-06 | — | — | EP | disclosed |
| EP-1005324-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-1998056348-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056334-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125380-A1 | Tricyclic rantes receptor ligands | CCR5, CCR1, CCL11 | ATP12A 4805/4885ATP1A1 3992/4885ATP1B1 4547/4885 |
| US-20030092674-A1 | Tricyclic rantes receptor ligands | CCR5, CCR1, CCL11 | ATP12A 4805/4885ATP1A1 3992/4885ATP1B1 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.